Identification of Potential Kinase Inhibitors within the PI3K/AKT Pathway of Leishmania Species.
PMID:34356660
From Genome to Drugs: New Approaches in Antimicrobial Discovery.
PMID:34177572
Mycobacterial drug discovery.
PMID:34085044
Genomics, Computational Biology and Drug Discovery for Mycobacterial Infections: Fighting the Emergence of Resistance.
PMID:33101362
Quantifying Gene Essentiality Based on the Context of Cellular Components.
PMID:32038710
Sequence-Derived Markers of Drug Targets and Potentially Druggable Human Proteins.
PMID:31803227
MycoResistance: a curated resource of drug resistance molecules in Mycobacteria.
PMID:31290951
Fluoromycobacteriophages Can Detect Viable Mycobacterium tuberculosis and Determine Phenotypic Rifampicin Resistance in 3-5 Days From Sputum Collection.
PMID:30026735
An integrative, multi-omics approach towards the prioritization of Klebsiella pneumoniae drug targets.
PMID:30018343
The Druggable Pocketome of Corynebacterium diphtheriae: A New Approach for in silico Putative Druggable Targets.
PMID:29487617
Target-Pathogen: a structural bioinformatic approach to prioritize drug targets in pathogens.
PMID:29106651
Decoding the similarities and differences among mycobacterial species.
PMID:28854187
Bioinformatics in translational drug discovery.
PMID:28487472
Data Intensive Genome Level Analysis for Identifying Novel, Non-Toxic Drug Targets for Multi Drug Resistant Mycobacterium tuberculosis.
PMID:28425478
An integrated structural proteomics approach along the druggable genome of Corynebacterium pseudotuberculosis species for putative druggable targets.
PMID:26041381
The future for early-stage tuberculosis drug discovery.
PMID:25689534